| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.03 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |